IL42401A - Antibiotic substances b-41,their production and their use as insecticides and acaricides - Google Patents

Antibiotic substances b-41,their production and their use as insecticides and acaricides

Info

Publication number
IL42401A
IL42401A IL42401A IL4240173A IL42401A IL 42401 A IL42401 A IL 42401A IL 42401 A IL42401 A IL 42401A IL 4240173 A IL4240173 A IL 4240173A IL 42401 A IL42401 A IL 42401A
Authority
IL
Israel
Prior art keywords
formula
hydrogen atom
methyl group
group
bond
Prior art date
Application number
IL42401A
Other versions
IL42401A0 (en
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of IL42401A0 publication Critical patent/IL42401A0/en
Publication of IL42401A publication Critical patent/IL42401A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G11/00—Antibiotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Dentistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Claims (11)

1. A compound having the formula wherein R, represents a hydrogen atom or a methyl group; R2 represents a methyl grou "or when 1 is hydrogen Rg may also represent a pyrroyloxymethyl group of the formula ; R_ represents a methyl group or an ethyl group? R^ and ^ are each a hydrogen atom, or, when Rg anc Rj are. each a methyl group, A may also represent a group of CH3 the formula -0C0CH-(CH2)j-CH-- in which case R^ is a hydroxy group; Rg and R^ together represent a C-0 bond, but when R^ , and R^ are each a. methyl group and R^ and R^.are each hydrogen, then Rg and R^ may also be each a hydrogen atom.
2. The compound of formula I in Claim 1, wherein R1 is a hydrogen atom, is a methyl group, R^ is a methyl group, R^ and R^ are each a hydrogen atom and Rg and R^ together represent a C-0 bond. - 20 » 42401/2
3. The compound of formula I in. Claim 1, wherein is a hydrogen atom, g is a methyl group, R.. is an ethyl group, R^ and Rpj are each a hydrogen atom and Rg and R^ together represent a 0-0 bond .
4. The compound of formula I in Claim 1 , wherein R^ is a methyl group, Rg is a methyl group, ^ is a methyl group, R^ and R,. are each a hydrogen atom and Rg and R^ together represent a C-0 bond.
5. The compound of formula I in Claim 1, wherein is a methyl group, Rg is a methyl group, R^ is an ethyl group, R^ and Rj are each a hydrogen atom and Rg and R^ together represent a C-0 bond.
6. The compound of formula I in Claim 1, wherein 1 is a hydrogen atom, 2 is the pyrroyloxymethyl group, R^ is a methyl group, R^ and Bp. are each a hydrogen atom and Rg and R^ together represent a C-0 bond.
7. The compound of formula I in Claim 1 , wherein R1 is a hydrogen atom, R2 is the pyrroyloxyme hyl group, R^ is an ethyl group, R^ and R-. are each a hydrogen atom and Rg and ^ together represent a C-0 bond.
8. A compound according to Claim 1 having the formula 42401/2 .,,
9. An antibiotic substance B-^l-Ag-. effective against harmful insects, said substance being a colorless amorphous powder form which is difficultly soluble in water and easily soluble in n-hexane, benzene, acetone, ethanol and chloroform and has the formula I in Claim 1 , in which R^ is a hydrogen atom, R5 is a methyl group, R., is a' methyl group, RA is a group of the formula _oco-CH-(C*i ) -CH » R5 iS ^^νοχ^ ' and Rg and R^ together represent a C-0 bond*; said substance . has a molecular -formula of C^gK^gO^ Q, a compositio of 71.75%Tcarbon and 8.26% hydrogen and the following ■ properties; molecular weights of 672.1 obtained by an osmometric method. in acetone and of 672 according 20 1 mass spectrum; a specific rotatory power of (° D ° · ' '\ +5*-° obtained with the concentration of a sample of 5 mg./2 ml. and the length of a layer of 10 cm. in acetone; no p a at a pK ranging from 2 to 12; absorption maximum in the ultraviolet region of the spectrum at 24-5 ιημ; characteristic absorption bands j in the infrared region shown in Fig. 11; nuclear . 1 magnetic resonance spectrum in (CD^^CO shown in I Fig. 20; main peaks of the mass spectrum 672, 181, j 153 and.151 obtained under the conditions of 75 eV j at ionization room temperature of 2o6eC. and a sample temperature of 120-190°C; and the following color reactions according to a thin layer chromatography, ■ yellow to iodine/chloroform, negative to ninhydrin, reddish purple to sulfuric acid and yellow to potassium permanganate.
10. An- antibiotic substance B-41-B^ effective against harmful insects, said substance bein a -29- 42401 / 3 ethanol and chloroform and has the formula I in Claim 1 , i ethyl is substance has a molecular formula of a composition of 68,006 carbon and 8·32# hydrogen and the following properties; a melting point of 176-178°C ; molecular weights of 629o5 obtained by an osmometric method in acetone and of 686 according to mass spectrum; a specific rotatory power of (° D = obtained with the concentration of a sample of 5 mg./2 ml. and. the length of a layer of 10 cm. in acetone; no pKa at a pH ranging from 2 to 12; absorption maximum in the ultraviolet region of the spectrum at 2 5 πιμ; characteristic absorption bands in the infrared region shown in Fig. 14; nuclear magnetic resonance spectrum in (CD^^CO shown in Fig. 23; main peaks of the mass spectrum .686, 414, 195, .167, 151 and 125 obtained under the conditions of 75 eV at ionization room temperature of · 200eC. and a sample temperature of 120-i90°C; and the following color reactions according to a thin layer chromatography", yellow to iodine/chloroform, negative to ninhydrin, reddish purple to sulfuric acid and yellow to potassium permanganate.
11. A process for producing antibiotic substances B-41-Aj, B-41-A2, B-41-Aj, B-41-A^, B-41-B- B-41-B2, B-41-B^, B-41-C^ and B-41-C2 which comprises cultur-ing a B-41-producing strain belongin to the genus Streptomyces-= and then recovering, either singly or ■ in the form of mixtures , said antibiotic .substances from the fermentation broth.
IL42401A 1972-06-08 1973-05-30 Antibiotic substances b-41,their production and their use as insecticides and acaricides IL42401A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP47057058A JPS4914624A (en) 1972-06-08 1972-06-08

Publications (2)

Publication Number Publication Date
IL42401A0 IL42401A0 (en) 1973-07-30
IL42401A true IL42401A (en) 1976-02-29

Family

ID=13044830

Family Applications (1)

Application Number Title Priority Date Filing Date
IL42401A IL42401A (en) 1972-06-08 1973-05-30 Antibiotic substances b-41,their production and their use as insecticides and acaricides

Country Status (11)

Country Link
JP (1) JPS4914624A (en)
BR (1) BR7304308D0 (en)
CH (2) CH585514A5 (en)
DE (1) DE2329486C2 (en)
ES (1) ES415591A1 (en)
FR (1) FR2187778B1 (en)
GB (1) GB1390336A (en)
IL (1) IL42401A (en)
IT (1) IT986430B (en)
SU (2) SU588926A3 (en)
ZA (1) ZA733857B (en)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5858164B2 (en) * 1975-09-06 1983-12-23 イシカワジマハリマジユウコウギヨウ カブシキガイシヤ Chisel Souchi
SE434277B (en) * 1976-04-19 1984-07-16 Merck & Co Inc SET TO MAKE NEW ANTIHELMINTICALLY EFFECTIVE ASSOCIATIONS BY CULTIVATING STREPTOMYCS AVERMITILIS
NZ186851A (en) * 1977-04-11 1984-12-14 Merck & Co Inc Glycosyloxy derivatives of milbemycin and parasiticidal compositions
US4093629A (en) * 1977-04-11 1978-06-06 Merck & Co., Inc. Derivatives of antibiotic substance milbemycin and processes therefor
PH15982A (en) * 1977-10-03 1983-05-18 Merck & Co Inc Selective hydrogenation producta of c-076 compounds and derivatives thereof
NZ188459A (en) * 1977-10-03 1982-09-07 Merck & Co Inc Derivatives of c-076 compounds and pesticidal compositions
PH16612A (en) * 1977-12-19 1983-11-28 Merck & Co Inc 13-halo and 13-deoxy derivatives of c-076 compounds
JPS5632481A (en) * 1979-08-23 1981-04-01 Sankyo Co Ltd Antibiotic b-41d, its preparation, and acaricide and anthelminthic agent and repellent containing the same as active constituent
JPS57139012A (en) * 1981-02-23 1982-08-27 Sankyo Co Ltd Anthelmintic composition
EP0102702B1 (en) * 1982-07-22 1987-07-29 Imperial Chemical Industries Plc Methods and compositions of combating pests
JPS60141293A (en) * 1983-12-28 1985-07-26 Kitasato Inst:The Novel carcinostatic antibiotic substance 81-484 and its production
US5169956A (en) * 1984-06-05 1992-12-08 American Cyanamid Company Macrolide antibiotic compounds
ES8704545A1 (en) * 1984-09-14 1987-04-01 Glaxo Group Ltd Antibiotic compounds and their preparation
GB8606120D0 (en) * 1986-03-12 1986-04-16 Glaxo Group Ltd Process
DE3750495T2 (en) * 1986-07-24 1995-02-23 Beecham Group Plc Milbemycin derivatives with parasiticidal activity, a process for their preparation and the compositions containing them.
US4831016A (en) * 1986-10-31 1989-05-16 Merck & Co., Inc. Reduced avermectin derivatives
DE3888936T2 (en) * 1987-11-03 1994-07-21 Beecham Group Plc Intermediates for the production of macrolide antibiotics with an anthelmintic effect.
GB8804440D0 (en) * 1988-02-25 1988-03-23 Pfizer Ltd Antiparasitic agents
GB8815967D0 (en) * 1988-07-05 1988-08-10 Pfizer Ltd Antiparasitic agents
GB8917064D0 (en) * 1989-07-26 1989-09-13 Pfizer Ltd Antiparasitic agent
US5290804A (en) * 1991-05-01 1994-03-01 Merck & Co., Inc. Anthelmintic milbemycin analogs of novel microorganisms
GB9205007D0 (en) * 1992-03-07 1992-04-22 Pfizer Ltd Antiparasitic agents
JP2952265B2 (en) * 1993-11-29 1999-09-20 井筒屋化学産業株式会社 Composition and method for preventing pine wilt
PT765879E (en) * 1995-09-29 2001-05-31 Sankyo Co 13-SUBSTITUTED DERIVATIVES OF MILBEMYCIN-5-OXYME PREPARATION AND USE AGAINST INSECTS AND OTHER PLAGUES
DE19613972A1 (en) * 1996-04-09 1997-10-16 Bayer Ag Injection formulations of avermectins and milbemycins based on castor oil
US6733767B2 (en) 1998-03-19 2004-05-11 Merck & Co., Inc. Liquid polymeric compositions for controlled release of bioactive substances
GB9825402D0 (en) 1998-11-19 1999-01-13 Pfizer Ltd Antiparasitic formulations
CA2460692C (en) 2001-09-17 2012-12-18 Eli Lilly And Company Pesticidal formulations
US7671034B2 (en) 2003-12-19 2010-03-02 Merial Limited Stabilized formulation of ivermectin feed premix with an extended shelf life
DE102004053964A1 (en) 2004-11-09 2006-05-11 Bayer Healthcare Ag Remedy for demodicosis
US8362086B2 (en) 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
CN101511795B (en) 2006-07-05 2013-09-18 安万特农业公司 1-aryl-5-alkylpyrazole derivative compounds, methods of making and methods of use thereof
PT3088384T (en) 2007-05-15 2019-03-22 Aventis Agriculture Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
AR074024A1 (en) 2008-11-14 2010-12-15 Merial Ltd COMPOSITE OF ARILAZOL-2-IL-CYANOETHYLAMIN ENANTIOMERICALLY ENRICHED, PESTICIATED COMPOSITION AND ITS USE TO PREVENT PARASITARY INFECTION
WO2010059529A2 (en) 2008-11-19 2010-05-27 Merial Limited Compositions comprising an aryl pyrazole and/or a formamidine, methods and uses thereof
EP2327410A1 (en) 2009-10-28 2011-06-01 Consiglio Nazionale Delle Ricerche - Infm Istituto Nazionale Per La Fisica Della Materia Avermectins and milbemycins for the treatment of flavivirus infections
ES2546100T3 (en) 2009-12-04 2015-09-18 Merial, Inc. Bis-organosulfurized pesticide compounds
PT3078664T (en) 2009-12-17 2019-05-31 Boehringer Ingelheim Animal Health Usa Inc Antiparasitic dihydroazole compositions
UA108641C2 (en) 2010-04-02 2015-05-25 PARASITICID COMPOSITION CONTAINING FOUR ACTIVE AGENTS AND METHOD OF APPLICATION
MX2013005414A (en) 2010-11-16 2013-08-29 Centre Nat Rech Scient Novel monensin derivatives for the treatment and prevention of protozoal infections.
US20120329832A1 (en) 2011-06-27 2012-12-27 Jean Delaveau Novel Insect-Repellent Coumarin Derivatives, Syntheses, and Methods of Use
AU2012275435B2 (en) 2011-06-27 2016-07-21 Boehringer Ingelheim Animal Health USA Inc. Amido-pyridyl ether compounds and compositions and their use against parasites
HUE042360T2 (en) 2011-09-12 2019-06-28 Merial Inc Anti-parasitic preparations containing the active ingredient isoxazoline, their preparation and use
US20130079394A1 (en) 2011-09-23 2013-03-28 Cnrs (Centre National Recherche Scientifique) Indirect modeling of new repellent molecules active against insects, acarids, and other arthropods
CA2855954C (en) 2011-11-17 2020-09-01 Merial Limited Compositions comprising an aryl pyrazole and a substituted imidazole, methods and uses thereof.
AP2014007874A0 (en) 2012-02-06 2014-08-31 Merial Ltd Parasiticidal oral veterinary compositions comprising systemetically- acting active agents, methods and uses thereof
JO3626B1 (en) 2012-02-23 2020-08-27 Merial Inc Topical formulations containing fipronil and permethrin and how to use them
CA2870956C (en) 2012-04-20 2020-03-31 Merial Limited Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof
NZ716598A (en) 2012-11-20 2017-02-24 Merial Inc Anthelmintic compounds and compositions and method of using thereof
SI2950795T1 (en) 2013-01-31 2018-07-31 Merial, Inc. A method of treating and treating leishmaniosis using feksinidazole
WO2015066277A1 (en) 2013-11-01 2015-05-07 Merial Limited Antiparisitic and pesticidal isoxazoline compounds
EP2886640A1 (en) 2013-12-18 2015-06-24 Riga Technical University Process for isolation of milbemycins A3 and A4
JP6682719B2 (en) 2014-04-17 2020-04-15 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド Use of malononitrile compounds to protect animals from parasites
NZ726874A (en) 2014-05-19 2018-03-23 Merial Inc Anthelmintic compounds
ES2723969T3 (en) 2014-06-19 2019-09-04 Merial Inc Parasiticidal compositions comprising indole derivatives, procedures and uses thereof
AU2015339096B2 (en) 2014-10-31 2018-08-02 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal composition comprising fipronil
UY36570A (en) 2015-02-26 2016-10-31 Merial Inc INJECTABLE FORMULATIONS OF PROLONGED ACTION THAT INCLUDE AN ISOXAZOLINE ACTIVE AGENT, METHODS AND USES OF THE SAME
CA2981797C (en) 2015-04-08 2023-11-21 Merial, Inc. Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof
RS62130B1 (en) 2015-05-20 2021-08-31 Boehringer Ingelheim Animal Health Usa Inc Anthelmintic depsipeptide compounds
WO2016191389A2 (en) 2015-05-27 2016-12-01 Merial, Inc. Compositions containing antimicrobial igy antibodies, for treatment and prevention of disorders and diseases caused by oral health compromising (ohc) microorganisms
UY37137A (en) 2016-02-24 2017-09-29 Merial Inc ANTIPARASITARY COMPOUNDS OF ISOXAZOLINE, INJECTABLE FORMULATIONS OF PROLONGED ACTION THAT INCLUDE THEM, METHODS AND USES OF THE SAME
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
JP2019535655A (en) 2016-10-14 2019-12-12 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド Insecticidal and parasiticidal vinylisoxazoline compounds
BR112019009977A2 (en) 2016-11-16 2019-08-27 Boehringer Ingelheim Animal Health Usa Inc anthelmintic depsipeptide compounds
UY37780A (en) 2017-06-26 2019-01-31 Merial Inc COMPOSITIONS OF PARASITICIATED GRANULES WITH DOUBLE ACTIVE PRINCIPLE, ITS METHODS AND USES
MX2020001724A (en) 2017-08-14 2020-07-29 Boehringer Ingelheim Animal Health Usa Inc Pesticidal and parasiticidal pyrazole-isoxazoline compounds.
US20210137960A1 (en) 2018-02-01 2021-05-13 Yale University Compositions and methods for inhibition of nuclear-penetrating antibodies
US11583545B2 (en) 2018-02-08 2023-02-21 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal compositions comprising eprinomectin and praziquantel, methods and uses thereof
MX2021000293A (en) 2018-07-09 2021-07-15 Boehringer Ingelheim Animal Health Usa Inc Anthelminthic heterocyclic compounds.
US11773066B2 (en) 2018-11-20 2023-10-03 Boehringer Ingelheim Animal Health USA Inc. Indazolylcyanoethylamino compound, compositions of same, method of making, and methods of using thereof
WO2020150032A1 (en) 2019-01-16 2020-07-23 Boehringer Ingelheim Animal Health USA Inc. Topical compositions comprising a neonicotinoid and a macrocyclic lactone, methods and uses thereof
AU2020231319A1 (en) 2019-03-01 2021-10-21 Boehringer Ingelheim Animal Health USA Inc. Injectable clorsulon compositions, methods and uses thereof
KR20220002890A (en) 2019-03-19 2022-01-07 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 Parasiticidal aza-benzothiophenes and aza-benzofuran compounds
BR112022000982A2 (en) 2019-07-22 2022-03-08 Intervet Int Bv Soft chewable veterinary dosage form
BR112022024156A2 (en) 2020-05-29 2023-02-14 Boehringer Ingelheim Animal Health Usa Inc ANTHELMINTIC HETEROCYLIC COMPOUNDS
EP4262789A1 (en) 2020-12-21 2023-10-25 Boehringer Ingelheim Vetmedica GmbH Parasiticidal collar comprising isoxazoline compounds
JP2024516912A (en) 2021-05-14 2024-04-17 シンジェンタ クロップ プロテクション アクチェンゲゼルシャフト Control of insect, acarine and nematode pests
WO2023203038A1 (en) 2022-04-19 2023-10-26 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
WO2025257633A1 (en) 2024-06-12 2025-12-18 Boehringer Ingelheim Vetmedica Gmbh Long-acting castor oil-containing injectable formulations and methods of use thereof

Also Published As

Publication number Publication date
AU5663173A (en) 1974-12-12
JPS4914624A (en) 1974-02-08
DE2329486C2 (en) 1984-01-12
FR2187778A1 (en) 1974-01-18
IL42401A0 (en) 1973-07-30
CH585789A5 (en) 1977-03-15
DE2329486A1 (en) 1973-12-20
IT986430B (en) 1975-01-30
SU1360574A3 (en) 1987-12-15
GB1390336A (en) 1975-04-09
SU588926A3 (en) 1978-01-15
FR2187778B1 (en) 1976-06-11
ES415591A1 (en) 1976-07-01
BR7304308D0 (en) 1974-08-29
CH585514A5 (en) 1977-03-15
ZA733857B (en) 1975-04-30

Similar Documents

Publication Publication Date Title
SE8001339L (en) ANTIHYPERCOLESTEREMIC MEDICINE, MONACOLINE K AND PREPARATION OF THEREOF
Schroeder et al. Inhibition of aflatoxin production and tentative identification of an aflatoxin intermediate “versiconal acetate” from treatment with dichlorvos
US4435423A (en) Anti-ulcer composition comprising terpenoid containing two functional groups and method of treating ulcers
Teunisson et al. Isolation and structure of a biologically reduced aflatoxin B1
Jüttner et al. The reducing capacities of cyanobacteria for aldehydes and ketones
JPS5661398A (en) Substance dc-45 and its preparation
WO1986001509A1 (en) Xenocoumacins
Nakamura et al. Structure of griseolutein A
JPS55310A (en) New antibiotic substance n-461, its preparation, and agricultural and horticultural fungicide comprising it as active constituent
JPS6024717B2 (en) antibiotic mycoplanesin
Chien et al. Microbial transformations of natural antitumour agents. Part 15. Metabolism of bruceantin by Streptomyces griseus
US4098998A (en) Aldehyde, oxime and phenylhydrazone derivatives of acid S, an antibiotic produced by Polyangium cellulosum var. fulvum
Stratton et al. A new metabolite of Streptomyces venezuelae: D-Threo-1-p-aminophenyl-2-dichloroacetamido-1, 3-propanediol
Steglich et al. Some problems in the structural elucidation of fungal metabolites
JPS57139079A (en) 8,9-epoxy derivative of antibiotic substance b-41 and its preparation
US3932620A (en) Ketones and ketoximes derived from acid S, an antibiotic produced by polyangium cellulosum var. fulvum
IE35230B1 (en) Antibiotic 67-694 and methods for production thereof
Balasubramanya et al. Degradation of carboxin (Vitavax) and oxycarboxin (Plantvax) by Pseudomonas aeruginosa isolated from soil
GB1500846A (en) Antibiotic a process for its preparation and its use as a medicament
AU573391B2 (en) Xenocoumacins
Medina-Castro Norprodigiosin
GB1504994A (en) Naphthyridinomycin antibiotics and preparation thereof
JPS57200389A (en) Fr900261 substance and its preparation
US3753862A (en) Method of making fungicidal substance against candida and candida-like,yeast-like fungi
JPS57176942A (en) Antibiotic substance mycoplanecin c derivative and its preparation